Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Schentag

Showing results (51-60 of 236) with videos related to

Pageof 24
Sort By:
Annals of Internal Medicine|November 1, 1981
Alteration of theophylline clearance and half-life by cimetidine in normal volunteersD P Reitberg, H Bernhard, J J Schentag
DICP : the Annals of Pharmacotherapy|February 1, 1990
Lack of effect of piroxicam on theophylline clearance in healthy volunteersC Maponga, J C Barlow, J J Schentag
Antimicrobial Agents and Chemotherapy|July 1, 1989
Effect of lomefloxacin on theophylline pharmacokineticsD E Nix, A Norman, J J Schentag
Drug Intelligence & Clinical Pharmacy|March 1, 1981
Cimetidine in systemic mastocytosisM J Berg, H Bernhard, J J Schentag
Clinical Pharmacology and Therapeutics|September 1, 1983
Hepatic encephalopathy and altered cimetidine kineticsJ A Ziemniak, H Bernhard, J J Schentag
Clinical Pharmacokinetics|August 19, 1999
Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobialsR C Li, M Zhu, J J Schentag
Drugs of Today (Barcelona, Spain : 1998)|July 25, 2003
Pharmacokinetics and metabolism of moxifloxacinP A Moise, M C Birmingham, J J Schentag
Antimicrobial Agents and Chemotherapy|August 1, 1984
Moxalactam penetration into normal heart valve, cardiac vegetations, and myocardium in relation to protein binding and physiological distribution spacesB C Fitzpatrick, F M Gengo, J J Schentag
Antimicrobial Agents and Chemotherapy|October 1, 1980
Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactionsJ A Pieper, R A Vidal, J J Schentag
Antimicrobial Agents and Chemotherapy|March 1, 1993
The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactionsR C Li, J J Schentag, D E Nix
Pageof 24

Showing results (51-60 of 236) with videos related to

Sort By:
Pageof 24
Annals of Internal Medicine|November 1, 1981
Alteration of theophylline clearance and half-life by cimetidine in normal volunteersD P Reitberg, H Bernhard, J J Schentag
DICP : the Annals of Pharmacotherapy|February 1, 1990
Lack of effect of piroxicam on theophylline clearance in healthy volunteersC Maponga, J C Barlow, J J Schentag
Antimicrobial Agents and Chemotherapy|July 1, 1989
Effect of lomefloxacin on theophylline pharmacokineticsD E Nix, A Norman, J J Schentag
Drug Intelligence & Clinical Pharmacy|March 1, 1981
Cimetidine in systemic mastocytosisM J Berg, H Bernhard, J J Schentag
Clinical Pharmacology and Therapeutics|September 1, 1983
Hepatic encephalopathy and altered cimetidine kineticsJ A Ziemniak, H Bernhard, J J Schentag
Clinical Pharmacokinetics|August 19, 1999
Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobialsR C Li, M Zhu, J J Schentag
Drugs of Today (Barcelona, Spain : 1998)|July 25, 2003
Pharmacokinetics and metabolism of moxifloxacinP A Moise, M C Birmingham, J J Schentag
Antimicrobial Agents and Chemotherapy|August 1, 1984
Moxalactam penetration into normal heart valve, cardiac vegetations, and myocardium in relation to protein binding and physiological distribution spacesB C Fitzpatrick, F M Gengo, J J Schentag
Antimicrobial Agents and Chemotherapy|October 1, 1980
Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactionsJ A Pieper, R A Vidal, J J Schentag
Antimicrobial Agents and Chemotherapy|March 1, 1993
The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactionsR C Li, J J Schentag, D E Nix
Pageof 24